This clinical trial studies the effect of a continuous glucose monitor application in improving outcomes in patients with poorly controlled type 2 diabetes and active cancer. Patient satisfaction with type 2 diabetes management influences medication-taking behavior as well as health outcomes. Adding continuous glucose monitor application to diabetes treatment plan after hospital discharge plan may improve patient satisfaction and reduce diabetes distress.
PRIMARY OBJECTIVE: I. Evaluate if addition of continuous glucose monitor (CGM) to diabetes treatment plan following inpatient hospitalization is associated with improved patient satisfaction with DM management in patients with cancer and poorly controlled type 2 diabetes mellitus. SECONDARY OBJECTIVES: I. Evaluate feasibility of CGM initiation upon hospital discharge. II. Evaluate effect of CGM on recognition of post-hospitalization hypoglycemia. III. Evaluate patient reported outcome of CGM incorporation into patient diabetes care burden. IV. Evaluate effect of CGM on depression score before and after CGM use. OUTLINE: Prior to hospital discharge, patients receive CGM application and education on how to apply the CGM, and how to use the sensor and its associated smart phone application (app). Patients also receive basic diabetes mellitus education. After hospital discharge, patients use CGM for up to 28 days.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
3
Receive basic diabetes mellitus education
Use CGM device and app
Ancillary studies
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) survey score
Descriptive statistics will summarize the sample characteristics and distribution of each variable. Change over time in continuous variables will be reported as paired t-test or nonparametric test as appropriate.
Time frame: From baseline to 4 weeks post-discharge
Change in DTSQ scores
Descriptive statistics will summarize the sample characteristics and distribution of each variable. Change over time in continuous variables will be reported as paired t-test or nonparametric test as appropriate.
Time frame: From baseline to 2 weeks post-discharge
Overall control
Descriptive statistics will summarize the sample characteristics and distribution of each variable.
Time frame: Up to 4 weeks post-discharge
Change in various measures of control
Descriptive statistics will summarize the sample characteristics and distribution of each variable. Change over time in continuous variables will be reported as paired t-test or nonparametric test as appropriate.
Time frame: From week 1 to week 4
Number of patients with successful data collection
Descriptive statistics will summarize the sample characteristics and distribution of each variable.
Time frame: At 2 weeks
Number of patients with successful data collection
Descriptive statistics will summarize the sample characteristics and distribution of each variable.
Time frame: At 4 weeks
Change in Patient Health Questionnaire scores
Descriptive statistics will summarize the sample characteristics and distribution of each variable. Change over time in continuous variables will be reported as paired t-test or nonparametric test as appropriate.
Time frame: From baseline to 4 weeks post-discharge
Incidence of adverse events
Will report the safety of continuous glucose monitor application and use. Descriptive statistics will summarize the sample characteristics and distribution of each variable.
Time frame: Immediately following inpatient hospitalization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.